Verastegui Jaime E, Hamada Yukihiro, Nicolau David P
a Center for Anti-infective Research and Development , Hartford Hospital , Hartford , CT , USA.
b Division of Infectious Diseases , Hartford Hospital , Hartford , CT , USA.
Expert Rev Clin Pharmacol. 2016 Aug;9(8):1039-45. doi: 10.1080/17512433.2016.1195683. Epub 2016 Jun 16.
Acute bacterial skin and skin structure infections (ABSSSI) have evolved over a relatively short period of time to become one of the most challenging medical problems encountered in clinical practice. Notably the high incidence of methicillin-resistant S. aureus (MRSA) across the continuum of care has coincided with increased outpatient failures and higher rates of hospital admissions for parental antibiotic therapy. Consequently the management of ABSSSI constitutes a tremendous burden to the healthcare system in terms of cost of care and consumption of institutional and clinical resources. This perspective piece discusses current and new approaches to the management of ABSSSI in a hospital setting and the need for a multifaceted approach. Treatment strategies for the management through the utilization of observation units (OU), Outpatient Parental Antibiotic Therapy (OPAT), and newly developed antibiotics for the use against skin infections caused by Gram-positive bacteria will be discussed in the context of ABSSSI.
急性细菌性皮肤及皮肤结构感染(ABSSSI)在相对较短的时间内演变成为临床实践中最具挑战性的医学问题之一。值得注意的是,在整个护理过程中耐甲氧西林金黄色葡萄球菌(MRSA)的高发病率与门诊治疗失败率增加以及因静脉用抗生素治疗而住院率升高同时出现。因此,就护理成本以及机构和临床资源的消耗而言,ABSSSI的管理给医疗保健系统带来了巨大负担。这篇观点文章讨论了医院环境中ABSSSI管理的当前和新方法以及采取多方面方法的必要性。将在ABSSSI的背景下讨论通过利用观察单元(OU)、门诊静脉用抗生素治疗(OPAT)以及新开发的用于治疗革兰氏阳性菌引起的皮肤感染的抗生素进行管理的治疗策略。